Medford, MA, United States of America

Lingling Dai

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lingling Dai. Retrieved from https://idiyas.com/inventor/lingling-dai-z22ygt4a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lingling Dai: Innovator in Protein Degradation

Introduction

Lingling Dai is a prominent inventor based in Medford, MA (US). She has made significant contributions to the field of biochemistry, particularly in the area of protein degradation. Her innovative work has the potential to impact the treatment of various disorders and diseases.

Latest Patents

Lingling Dai holds 1 patent for her invention titled "Compounds, compositions, and methods for protein degradation." This patent discloses compounds that specifically target SMARCA2, SMARCA4, or BRM, leading to their degradation. The compositions and methods outlined in her patent are aimed at treating associated disorders and diseases, showcasing her commitment to advancing medical science.

Career Highlights

Lingling Dai is affiliated with the Dana-Farber Cancer Institute Inc., where she continues her research and development efforts. Her work at this esteemed institution allows her to collaborate with other leading scientists and contribute to groundbreaking discoveries in cancer treatment.

Collaborations

Some of her notable coworkers include Deyao Li and Jun Qi. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Lingling Dai's contributions to protein degradation research exemplify her dedication to improving healthcare outcomes. Her innovative patent and work at the Dana-Farber Cancer Institute Inc. position her as a key figure in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…